Dechra Pharmaceuticals PLC Director/PDMR Shareholding (8577I)
June 22 2017 - 2:36AM
UK Regulatory
TIDMDPH
RNS Number : 8577I
Dechra Pharmaceuticals PLC
22 June 2017
22 June 2017
Dechra Pharmaceuticals PLC
Notification of Transactions by Persons Discharging Managerial
Responsibilities
Dechra Pharmaceuticals PLC has been notified that on 21 June
2017 Ian Page, Director, sold 134,500 ordinary shares in the
Company at a price of GBP19.27 each.
Following this disposal Ian Page's beneficial interest in the
Company is 676,808 shares (0.726% of the current issued share
capital).
The Notification of Dealing Forms set out below are provided in
accordance with Article 19.3 of MAR.
Notification of Dealing Form
1. Details of the Person Discharging Managerial Responsibility
("PDMR")/person closely associated with them ("PCA")
--- ------------------------------------------------------------------------
a) Name Ian Page
--- ------------------------------------ ----------------------------------
2. Reason for the notification
--- ------------------------------------------------------------------------
a) Position/status Director
--- ------------------------------------ ----------------------------------
b) Initial notification/ Initial Notification
amendment
--- ------------------------------------ ----------------------------------
3. Details of the Issuer
--- ------------------------------------------------------------------------
a) Name Dechra Pharmaceuticals PLC
--- ------------------------------------ ----------------------------------
b) LEI code 213800J4UVB5OWG8VX82
--- ------------------------------------ ----------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
where transactions have been conducted
--- ------------------------------------------------------------------------
a) Description Ordinary Shares of 1 pence each
of the financial
instrument
ISIN: GB0009633180
Identification
code
--- ------------------------------------ ----------------------------------
b) Nature of the Sale of Shares
transaction
--- ------------------------------------ ----------------------------------
c) Price(s) and Price(s) Volume(s)
volumes(s)
GBP19.27 134,500
--- ------------------------------------ ---------------- ----------------
d) Aggregated information 15,000 at 1942p
* Aggregate volume 7,500 at 1934.49p
13,000 at 1935p
7,500 at 1935.42p
* Price 7,000 at 1931.32p
3,500 at 1930.6p
27,500 at 1927.5p
* Total 14,000 at 1925p
5,000 at 1925p
12,500 at 1926.42p
20,000 at 1910p
2,000 at 1910.41p
Total
134,500
1927.64p
--- ------------------------------------ ----------------------------------
e) Date of the 21 June 2017
transaction
--- ------------------------------------ ----------------------------------
f) Place of the London Stock Exchange
transaction
--- ------------------------------------ ----------------------------------
For further information, please contact:
Telephone number: 01606 814730
About Dechra
Dechra is an international specialist veterinary pharmaceuticals
and related products business. Our expertise is in the development,
manufacture, and sales and marketing of high quality products
exclusively for veterinarians worldwide. Dechra's business is
unique as the majority of its products are used to treat medical
conditions for which there is no other effective solution or have a
clinical or dosing advantage over competitor products. For more
information please visit: www.dechra.com
Trademarks
Dechra and the Dechra "D" logo are registered trademarks of
Dechra Pharmaceuticals PLC.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHOKBDNOBKKPAB
(END) Dow Jones Newswires
June 22, 2017 03:36 ET (07:36 GMT)
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From Apr 2024 to May 2024
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From May 2023 to May 2024
